176 related articles for article (PubMed ID: 12122271)
1. Towards the treatment of saphenous vein bypass graft failure--a perspective of the Bristol Heart Institute.
Angelini GD; Jeremy JY
Biorheology; 2002; 39(3-4):491-9. PubMed ID: 12122271
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of saphenous vein graft failure: a brief overview of interventions.
Shukla N; Jeremy JY
Curr Opin Pharmacol; 2012 Apr; 12(2):114-20. PubMed ID: 22321569
[TBL] [Abstract][Full Text] [Related]
3. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
4. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
[TBL] [Abstract][Full Text] [Related]
5. On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents.
Jeremy JY; Gadsdon P; Shukla N; Vijayan V; Wyatt M; Newby AC; Angelini GD
Biomaterials; 2007 Feb; 28(6):895-908. PubMed ID: 17113144
[TBL] [Abstract][Full Text] [Related]
6. The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
Wan S; Yim AP; Johnson JL; Shukla N; Angelini GD; Smith FC; Dashwood MR; Jeremy JY
J Thorac Cardiovasc Surg; 2004 May; 127(5):1317-22. PubMed ID: 15115988
[TBL] [Abstract][Full Text] [Related]
7. Role of osteopontin in the development of neointimal hyperplasia in vein grafts.
Kang N; Ng CS; Hu J; Qiu ZB; Underwood MJ; Jeremy JY; Wan S
Eur J Cardiothorac Surg; 2012 Jun; 41(6):1384-9. PubMed ID: 22219474
[TBL] [Abstract][Full Text] [Related]
8. Differential, time-dependent effects of perivenous application of fibrin glue on medial thickening in porcine saphenous vein grafts.
Wan S; Arifi AA; Chan MC; Yip JH; Ng CS; Chow LT; Yim AP; Jeremy JY
Eur J Cardiothorac Surg; 2006 May; 29(5):742-6; discussion 747. PubMed ID: 16581260
[TBL] [Abstract][Full Text] [Related]
9. Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
Wan S; Shukla N; Yim AP; Johnson JL; Angelini GD; Jeremy JY
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):494-500. PubMed ID: 17258588
[TBL] [Abstract][Full Text] [Related]
10. Periadventitial rapamycin-eluting microbeads promote vein graft disease in long-term pig vein-into-artery interposition grafts.
Rajathurai T; Rizvi SI; Lin H; Angelini GD; Newby AC; Murphy GJ
Circ Cardiovasc Interv; 2010 Apr; 3(2):157-65. PubMed ID: 20332383
[TBL] [Abstract][Full Text] [Related]
11. Therapeutics of vein graft intimal hyperplasia: 100 years on.
Wallitt EJ; Jevon M; Hornick PI
Ann Thorac Surg; 2007 Jul; 84(1):317-23. PubMed ID: 17588453
[TBL] [Abstract][Full Text] [Related]
12. Bypass graft disease: analysis of proliferative activity in human aorto-coronary bypass grafts.
Hilker M; Buerke M; Lehr HA; Oelert H; Hake U
Heart Surg Forum; 2002; 5 Suppl 4():S331-41. PubMed ID: 12759206
[TBL] [Abstract][Full Text] [Related]
13. External support in preventing vein graft failure.
Hu J; Wan S
Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):615-22. PubMed ID: 23087319
[TBL] [Abstract][Full Text] [Related]
14. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.
Schepers A; Eefting D; Bonta PI; Grimbergen JM; de Vries MR; van Weel V; de Vries CJ; Egashira K; van Bockel JH; Quax PH
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2063-9. PubMed ID: 16825596
[TBL] [Abstract][Full Text] [Related]
15. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.
Semsroth S; Stigler RG; Bernecker OY; Ruttmann-Ulmer E; Troppmair J; Macfelda K; Bonatti JO; Laufer G
Eur J Cardiothorac Surg; 2009 Mar; 35(3):515-20. PubMed ID: 19167904
[TBL] [Abstract][Full Text] [Related]
16. Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties.
Mekontso-Dessap A; Kirsch M; Guignambert C; Zadigue P; Adnot S; Loisance D; Eddahibi S
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):651-8. PubMed ID: 16515919
[TBL] [Abstract][Full Text] [Related]
17. Opportunities for gene therapy in preventing vein graft failure after coronary artery bypass surgery.
Baker AH; Yim AP; Wan S
Diabetes Obes Metab; 2006 Mar; 8(2):119-24. PubMed ID: 16448515
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
Schachner T; Steger C; Heiss S; Bonaros N; Sterlacci W; Laufer G; Bonatti J
Eur J Cardiothorac Surg; 2007 Dec; 32(6):906-11. PubMed ID: 17923411
[TBL] [Abstract][Full Text] [Related]
19. A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening.
Jeremy JY; Bulbulia R; Johnson JL; Gadsdon P; Vijayan V; Shukla N; Smith FC; Angelini GD
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1766-72. PubMed ID: 15173735
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1).
Wan S; Shukla N; Angelini GD; Yim AP; Johnson JL; Jeremy JY
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1033-9. PubMed ID: 17903525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
